Owen Witte Net Worth & Insider Trades

Owen Witte Allogene Therapeutics, Inc

As of June 23, 2022

What is Owen Witte's Net Worth?

The current estimated net worth of Allogene Therapeutics, Inc's Owen Witte is estimated to be about $5.38M . Owen Witte owns about 233,271 units of Allogene Therapeutics, Inc common stock. In the last 4 years at Allogene Therapeutics, Inc, Owen Witte has sold an estimated value of $729.72K worth.

What is Owen Witte's Past Insider Trading?

Owen Witte's largest purchase order was 52,432 units , worth over $270K on October 17, 2018. Owen Witte's largest sale order was 9,969 units , worth over $249.72K on June 11, 2021. In total, Owen Witte has made about 8 transactions over 4 years of their time at Allogene Therapeutics, Inc. Owen Witte usually trades in June, with the busiest year in 2021. The most recent transaction was a sale order of 10,000 units , worth over $117.6K on June 23, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Owen Witte's' Mailing Address?

  • Mailing address is C/o Allogene Therapeutics, Inc. 210 East Grand Avenue South San Francisco CA 94080 CA

Allogene Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
David Chang, M.D., Ph.D. 2020 $675,000 - - $6,550,535 $506,250 $83,256 $7,815,041
David Chang, M.D., Ph.D. 2019 $600,000 - $4,651,970 $5,327,140 $363,000 $250,000 $11,192,110
David Chang, M.D., Ph.D. 2018 $362,413 - $8,948,152 $3,070,331 $217,641 $250,000 $12,848,537
Eric Schmidt, Ph.D. 2020 $440,000 - $561,176 $1,262,643 $220,000 - $2,483,819
Eric Schmidt, Ph.D. 2019 $425,000 - $1,328,366 $1,519,700 $187,000 - $3,460,066
Eric Schmidt, Ph.D. 2018 $201,232 - - $2,299,658 $88,099 - $2,588,989
Rafael Amado, M.D. 2020 $510,000 $75,000 $561,176 $1,262,643 $255,000 - $2,663,819
Rafael Amado, M.D. 2019 $145,833 - $4,249,976 $2,759,623 $71,726 $225,000 $7,452,158
Alison Moore, Ph.D. 2020 $440,000 - $561,176 $1,262,643 $220,000 - $2,483,819
Alison Moore, Ph.D. 2019 $425,000 - $996,275 $1,519,700 $187,000 - $3,127,975
Alison Moore, Ph.D. 2018 $233,265 - - $1,401,225 $102,124 $100,000 $1,836,614
Veer Bhavnagri 2020 $425,000 - $537,490 $1,211,953 $212,500 $9,385 $2,396,328
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1737287/000173728721000013/allo-20210423xdef14axproxy.htm

What are Allogene Therapeutics, Inc's Past Insider Trades?

Allogene Therapeutics, Inc's most recent insider trade came on August 2, 2022 by Rafael Amado who sold 2,000 units worth $23.94K . In the last 4 years, insiders at Allogene Therapeutics, Inc have sold an estimated value of $151.81M and bought an estimated value of $33.14M worth of shares. Insider trading is most common in March, with the busiest year in 2020. The most active traders at the company are David D Chang, President and CEO,  Veer Bhavnagri, General Counsel,  and Alison Moore, Chief Technical Officer .

Allogene Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1